1. Pharma execs use telehealth in innovative marketing — Novo Nordisk gets breakthrough status in NASH for semaglutide — Regeneron antibody clinical trial hit by safety concerns — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Happenings...

Discussion in 'i3 Research' started by Anonymous, May 25, 2013 at 5:53 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    I don't see ads in trade publications for nearly a year. Don't see many headlines in the online industry publications. Just radio silence. What has happened with this company, other than its many recent name changes: i3 Research/inVentiv/Pharmanet-i3/inVentiv Clinical?
     

  2. Anonymous

    Anonymous Guest

    I've noticed that as well. They were quite visible back in the day with ads, articles in magazines, etc. before inventiv bought them. It's been quiet for a long time now. Am guessing the former PR machine when it was I3 is no longer in place. That, or they are broke.
     
  3. Anonymous

    Anonymous Guest

    Heard that all of i3 Research/inVentiv/Pharmanet-i3/inVentiv Clinical is broke. Start sending out your resume...quick!!
     
  4. Anonymous

    Anonymous Guest

    It is so broke...moral is at an all time low...all of middle management has left for greener pastures...15 in total since May...the qualifications of some of the newbies is pathetic...its not about what you know...or the work experience you possess...its all about who you know...